Back
ADMA Biologics Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
60
ADMA
ADMA Biologics
Last Price:
$17.44
Seasonality Move:
2.93%
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
$118.99
Seasonality Move:
12.18%
Buy
60
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
-
The current ADMA Biologics [ADMA] share price is $17.40. The Score for ADMA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ADMA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $118.97. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $17.40Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADMA is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $118.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
ADMA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 36.96 | Sell |
Chaikin Money Flow: | -1885228 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.47 - 20.95) | Sell |
Bollinger Bands (100): | (15.72 - 20.54) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 43.28 | Sell |
Chaikin Money Flow: | -1117882 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (112.92 - 130.54) | Sell |
Bollinger Bands (100): | (118.37 - 135.77) | Sell |
ADMA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.44 | Sell |
20-day SMA: | 19.54 | Sell |
50-day SMA: | 18.85 | Sell |
200-day SMA: | 13.53 | Buy |
8-day EMA: | 18.31 | Sell |
20-day EMA: | 19.03 | Sell |
50-day EMA: | 18.96 | Sell |
200-day EMA: | 14.51 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 123.1 | Sell |
20-day SMA: | 125.31 | Sell |
50-day SMA: | 122.99 | Sell |
200-day SMA: | 129.64 | Sell |
8-day EMA: | 122.43 | Sell |
20-day EMA: | 123.17 | Sell |
50-day EMA: | 123.7 | Sell |
200-day EMA: | 126 | Sell |
ADMA Biologics Earnings Growth & ADMA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.17 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.75 per share, and an increase next year of $7.84 per share.
ADMA Biologics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |